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ARTICLE
Structure of amyloid-β (20-34) with
Alzheimer’s-associated isomerization at Asp23
reveals a distinct protofilament interface
Rebeccah A. Warmack 1, David R. Boyer1, Chih-Te Zee1, Logan S. Richards1, Michael R. Sawaya 1,2,3,
Duilio Cascio 1,2,3, Tamir Gonen 2,4,5,6, David S. Eisenberg 1,2,3,4,5 & Steven G. Clarke1,2
Amyloid-β (Aβ) harbors numerous posttranslational modifications (PTMs) that may affect
Alzheimer’s disease (AD) pathogenesis. Here we present the 1.1 Å resolution MicroED
structure of an Aβ 20–34 fibril with and without the disease-associated PTM, L-isoaspartate,
at position 23 (L-isoAsp23). Both wild-type and L-isoAsp23 protofilaments adopt β-helix-like
folds with tightly packed cores, resembling the cores of full-length fibrillar Aβ structures, and
both self-associate through two distinct interfaces. One of these is a unique Aβ interface
strengthened by the isoaspartyl modification. Powder diffraction patterns suggest a similar
structure may be adopted by protofilaments of an analogous segment containing the heri-
table Iowa mutation, Asp23Asn. Consistent with its early onset phenotype in patients,
Asp23Asn accelerates aggregation of Aβ 20–34, as does the L-isoAsp23 modification. These
structures suggest that the enhanced amyloidogenicity of the modified Aβ segments may
also reduce the concentration required to achieve nucleation and therefore help spur the
pathogenesis of AD.
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A prevalent theory for the biochemical basis of Alzheimer’sdisease (AD) is the amyloid cascade hypothesis, whichdescribes the aggregation of the Aβ peptide into oligo-
meric or fibrous structures that then trigger the formation of
neurotoxic tau neurofibrillary tangles1–3. The Aβ peptide is sub-
ject to a number of posttranslational modifications (PTMs) that
may affect its aggregation in vivo4. Specifically, Aβ phosphor-
ylation (Ser8, Ser26), pyroglutamylation (Glu3, Glu11), nitration
(Tyr10), and racemization/isomerization (Asp1, Asp7, Asp23,
Ser26) have been shown in vitro to increase the aggregation
propensity or neurotoxicity of the Aβ 1–42 peptide5–11, while
other modifications, such as dityrosine crosslinking (Tyr10), have
been shown to increase the stability of the Aβ aggregates12.
Isomerized products of aspartic acid residues perturb protein
structure by rerouting the peptide backbone through the side
chain β-carbonyl. This age-dependent modification introduces a
methylene group within the polypeptide backbone and thus may
have a significant effect on the structure of Aβ oligomers or
fibrils13–15. In addition, the isopeptide bond is resistant to
degradation, potentially increasing the concentration of the iso-
merized Aβ form with respect to the native peptide. Despite the
presence of a repair enzyme in the brain, the L-isoaspartate
(D-aspartate) O-methyltransferase (PCMT1) for L-isoaspartate,
the isomerization of Aβ Asp1, Asp7, and Asp23 has been iden-
tified within AD brain parenchyma16,17. In the cases of the
heritable early-onset AD Iowa mutation (Asp23Asn), 25–65% of
Asn23 residues have been shown to be isomerized in frontal lobe
tissues18, consistent with the increased rates of spontaneous
deamidation/isomerization of asparagine relative to aspartate19.
In vitro studies demonstrate that L-isoaspartate at Asp23 (L-
isoAsp23) significantly accelerates Aβ 1–42 fibril formation, while
L-isoAsp7 alone does not11,20. Subsequent studies using peptides
with multiple sites of isomerization showed only minor acceler-
ated aggregation of the tri-isomerized species (1, 7, and 23), over
the di-isomerized species (7 and 23)18. Taken together, these
results suggest that among the known sites of Asp isomerization
in Aβ, L-isoAsp23 is primarily responsible for the increase in
aggregation propensity in vitro.
Given the relevance of the isomerization of Asp23 to both
sporadic and hereditary Iowa mutant forms of AD, we sought to
discover the structural basis for its acceleration of fibril
formation10,17,18. As a platform for evaluating this modification,
we chose synthetically generated 15-mer peptides encoding resi-
dues 20–34 of the Aβ peptide (Aβ20–34) with and without an L-
isoAsp modification at position 23 and spanning the core of
known Aβ fibril structures21–29. Challenged by the small size of
crystals formed by this segment, we employed the cryo-electron
microscopic (cryo-EM) method microcrystal electron diffraction
(MicroED) to determine the structures. The structures of Aβ20–34
and Aβ20–34, isoAsp23, determined to 1.1 Å resolution by direct
methods, reveal with atomic detail conserved kinked β-helix-like-
turns with complex features similar to those observed previously
at lower resolution in the cores of fibrillar Aβ 1–42, as well as a
distinct pair of protofilament interfaces. Our results suggest that
the L-isoAsp23 residue facilitates the formation of a more stable
form of this unique interface, promoting enhanced fiber forma-
tion and stability. The length of these peptide segments, four
residues longer than any other crystallographically determined
amyloid structures30–33, is key in facilitating their complex fold—
a conformation more representative of the full-length Aβ fibrils.
Results
Fibril formation and characterization of Aβ20–34 peptides. Six
early-onset hereditary Alzheimer’s mutations and two PTMs,
including the isomerized Asp23, are localized in the Aβ 1–42
peptide to a region spanning six residues from Ala21 to Ser26
near the center of the peptide (Fig. 1a, b)17,34,35. The amyloid-
forming propensity of segments in this region of Aβ was assessed
using a computational method of predicting steric zippers by a
threading protocol (ZipperDB36). This method highlights a
region of Aβ from Asn27 to Gly37 with high aggregation pro-
pensity near the site of Asp23 isomerization (Fig. 1b). To char-
acterize segments containing an isomerized Asp residue at
position 23, we utilized synthetic 15 residue peptides spanning
the Aβ residues 20–34 (Aβ20–34) in which Asp23 was substituted
with either an L-Asn residue (Iowa mutant; Aβ20–34, Asp23Asn) or
an L-isoAsp residue (Aβ20–34, isoAsp23).
To evaluate the effect of these variations on this 15-residue
segment of Aβ, we assayed its capacity to form fibrils as measured
by light scattering at 340 nm (Fig. 1c). Both the peptide based on
the Iowa mutant (Aβ20–34, Asp23Asn) and the peptide based on L-
isoAsp23 (Aβ20–34, isoAsp23) demonstrated significantly enhanced
fibril formation over that of Aβ20–34, with the Iowa mutant
peptide displaying the fastest initial rate of fibril formation
(Fig. 1c). Fibers of the native peptide at this concentration
(1.6 mM) were not observed by light scattering or EM. We further
discovered that only 34% of these Aβ20–34, isoAsp23 aggregates
could be methylated by the L-isoAsp repair protein carboxyl
methyltransferase (PCMT1) in vitro (Supplementary Fig. 1).
These data suggest that a majority of the L-isoAsp sites are
occluded from the normal repair pathway once in
this aggregate form.
To determine the ability of these modified forms to accelerate
the aggregation of native peptide, seeding of 3.2 mM Aβ20–34 was
performed using 10 μM final concentrations of pre-aggregated
seeds of Aβ20–34, Aβ20–34, Asp23Asn, and Aβ20–34, isoAsp23 (Fig. 1d).
The addition of each of the preformed aggregates caused
significant acceleration in the onset of fiber formation. The
largest shift occurred with the native Aβ20–34 seed, followed by
isomerized Aβ20–34, isoAsp23 and Aβ20–34, Asp23Asn. Powder
diffraction performed on the final aggregates revealed nearly
identical sets of reflections, suggesting that the three seeds have
similar enough structures to template wild-type (WT) Aβ20–34
aggregates whose diffraction resembles unseeded fibrils (Supple-
mentary Fig. 2a). Fibrillization experiments of full-length Aβ
1–40 with and without the L-isoAsp modification at residue 23
reveal that the isomerized species displays a shorter lag time,
consistent with the results obtained with the corresponding
Aβ20–34 peptides (Supplementary Fig. 2b; Fig. 1c). Thus, while the
isomerized form may be only a minor component of the in vivo
Aβ population, it aggregates at a faster rate and can cross-seed the
native form efficiently in vitro.
In contrast to the results obtained with 1.6 mM Aβ20–34,
increasing the concentration to 3.2 mM Aβ20–34 did yield
aggregates ~77 nm in width (Fig. 1c, d). Importantly, light
scattering under these conditions for this native peptide is not
detected until 3.5 h at the earliest, while shifts in light scattering
for the 1.6 mM isomerized and mutated peptides were detected by
1.5 and 0.5 h, respectively (Fig. 1d). Direct comparisons of
formation rates were complicated by the insolubility of the
Aβ20–34, Asp23Asn peptide at high concentrations, but the delayed
onset of even the 3.2 mM Aβ20–34 incubation compared to the
1.6 mM Aβ20–34, Asp23Asn and Aβ20–34, isoAsp23 incubations also
support the increased rates of aggregation of the mutated and
isomerized peptides (Fig. 1c, d).
Fibrils of each segment were also investigated for their
resistance to dissociation by dilution into increasing concentra-
tions of sodium dodecyl sulfate (SDS) at 70 °C as measured by
light scattering at 340 nm (Fig. 2). Fibrils of the native 15-residue
Aβ segment appeared to partially dissolve upon dilution into the
SDS-free buffer, although remaining aggregates were found by
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EM. However, these were completely dissolved upon incubation
with 1% SDS and higher concentrations (Fig. 2). In contrast, the
isomerized peptide showed increased resistance to dissolution
compared to the native peptide and still showed light scattering
at a concentration of 2% SDS, though no more aggregates were
seen at 5% SDS (Fig. 2b). The fibrils of the Iowa mutant appeared
to be largely unaffected by dilution even at the highest
concentrations of SDS, with no significant changes observed in
the levels of light scattering. However, the aggregates in 5% SDS
seen by EM appeared to be less bundled than at lower
concentrations (Fig. 2b). These results show that alterations of
the structure at Asp23 strongly contribute to fibril formation and
stability.
Crystallization and data collection of the Aβ20–34 segments. To
understand the atomic structural basis for changes in the prop-
erties of the isomerized peptide, we sought to crystallize it in the
amyloid state. Vapor diffusion screening yielded no crystals large
enough for analysis by conventional X-ray crystallography for
either the Aβ20–34 or the Aβ20–34, isoAsp23 segment. Instead
ordered nanocrystals of the native segment were obtained with
continuous shaking at 1200 rpm, and ordered nanocrystals of the
isomerized segment were generated with constant mixing using
an acoustic resonant shaker37,38 for analysis by MicroED39,40 as
described in the “Methods” section. Nanocrystals obtained in
varying buffer conditions were evaluated by morphology and
diffraction via light and EM, respectively. Those formed under
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the most promising conditions were used as seeds for additional
rounds of batch crystal formation. The optimal crystallization
condition for the isomerized segment was 50 mM Tris, pH 7.6,
150 mM NaCl, and 1% dimethyl sulfoxide (DMSO) for 48 h with
2% seeds. Crystals of the native segment grew in 50 mM Tris, pH
7.5, 150 mM NaCl, and 1% DMSO for 30 h without seeding.
Isomerized crystal trials produced densely bundled nanocrystals
that could not be disaggregated by sonication and freeze–thawing.
However, washing crystal solutions with a 0.75% (w/v) solution of
β-octyl glucoside in TBS, pH 7.6 yielded a higher number of
single crystals for subsequent data collection. Dilution one to one
in buffer yielded sufficient single crystals of the native segment for
data collection (Fig. 3a, d). Data were collected on a Thermo
Fisher TALOS Arctica microscope operating at 200 kV using a
bottom mount CetaD CMOS detector. Each Aβ20–34 nanocrystal
could be rotated continuously up to 140 degrees during data
collection. A 1.1-Å-resolution structure was obtained by direct
methods for each segment as described in the “Methods” section;
refinement statistics for the structures are shown in Table 1.
MicroED structures of Aβ20–34 and Aβ20–34, isoAsp23 segments.
The structures of both the Aβ20–34 and the Aβ20–34,isoAsp23
protofilaments reveal parallel, in-register architectures in which
individual peptide chains stack through backbone hydrogen
bonds every 4.8 and 4.9 Å along the protofilament axis, respec-
tively (Fig. 3). In cross-section, both protofilaments appear tri-
angular owing to sharp turns (β-arches) at Gly25 and Gly29,
which divide each chain into three short, straight segments
(Fig. 3b, e and Supplementary Fig. 3a). When compared with the
structures in the protein databank, the three-sided Aβ20–34,iso-
Asp23 structure aligns best with a β-helical antifreeze protein from
Marinomonas primoryensis but lacks linker regions between each
stacked chain. We thus designate this amyloid motif as a β-helix-
like turn (Supplementary Fig. 4)41,42. At the central core of both
Aβ20–34 and the Aβ20–34,isoAsp23 protofilaments are the buried
side chains of Phe20, Ala21, Val24, Asn27, and Ile31 in a zipper-
like “intraface” that is completely dry. The side chain of Asn27
further stabilizes the assembly by forming a ladder of hydrogen
bonds (polar zipper) along the length of the protofilament43
(Supplementary Fig. 3b).
Each protofilament self-associates with neighboring protofila-
ments in the crystals through two distinct interfaces. Interface A
in both structures resembles a canonical steric zipper—with
intersheet distances of 8.3 and 9.1 Å for the native and
isomerized, respectively (Fig. 3b, e). Both are lined by the
hydrophobic side chains of Ala30, Ile32, and Leu34 that are
related by 21 screw symmetry (steric zipper symmetry class 144).
Interface A is completely dry owing to a high Sc of 0.73 in the
native and 0.62 in the isomerized. This interface buries
approximately 130 Å2 per chain in the native form and 131 Å2
in the isomerized form.
Unlike the dry steric zipper interface A, six water molecules
line the second Aβ20–34 interface, which we designate the “L-Asp
Interface B” (Fig. 3b, e). Here the protofilaments are also related
by a two-fold screw symmetry axis. Nearest this central axis,
Gly25 and Ser26 contact their symmetry partners across the
interface, separated by only 3.5 Å. Furthest from the axis, Asp23
and Lys28 from opposing protofilaments form charged pairs. In
between each of these two regions is a solvent channel with the
three ordered waters, yielding low shape complementarity (Sc=
0.43) to this interface overall. In contrast, in the Aβ20–34,isoAsp23
“L-isoAsp interface B” the truncated side chain of the L-isoAsp23
residue no longer forms a charged pair with Lys28 and instead the
isomerized protofilaments form a completely dry interface
containing the methylene group of L-isoAsp23, Val24, Gly25,
and Ser26 with high surface complementarity (Sc= 0.81; Fig. 3e).
This interface is tightly mated over its entire surface with an
average distance of 4.0 Å between the backbones. Interface B
buries approximately 139 and 122 Å2 per chain for the native and
isomerized forms, respectively. The exclusion of water molecules
from the L-isoAsp interface B likely results in a favorable gain in
entropy for the structure, and there are attractive van der Waals
forces along the tightly mated residues L-isoAsp23-Ser26.
Powder diffraction studies of Aβ peptides. X-ray powder dif-
fraction (XRD) patterns revealed that the fibrils of Aβ20–34 seg-
ments appear largely isomorphous, sharing major reflections at
~4.7, 10, 12.2, 14, and 29–31 Å (Fig. 4a, b). The similarity among
the powder diffraction patterns of Aβ20–34, isoAsp23, Aβ20–34,
Asp23Asn, and Aβ20–34 indicates that Aβ20–34, Asp23Asn mimics the
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structures of the native and isomerized segments. We modeled an
L-Asn residue at position 23 of the Aβ20–34, isoAsp23 structure to
see if the native L-amino acid could be accommodated in the dry
L-isoAsp interface B (Fig. 4c, right panel). The L-Asn residue was
integrated into the Aβ20–34, isoAsp23 interface B scaffold without
significant clashes. However, this Asn model lacks a backbone
hydrogen bond extending between the isoAsp23 amide carboxyl
to the Val24 amide nitrogen of the adjacent protofilament that is
present in our Aβ20–34, isoAsp23 structure (Fig. 4c). The residue at
site 23 has to adopt an allowed, but unusual left-handed helical
conformation to form the L-isoAsp interface B. Both the
methylene of the isoAsp residue and the isoAsp23 to Val24 main
chain hydrogen bond may help stabilize this structure. This
backbone hydrogen bond is present in the native Aβ20–34 struc-
ture (Fig. 4c). In this native structure, the Asp main chain adopts
a more canonical β-sheet conformation, but the side chain
a
L34
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protrudes toward the opposite protofilament, prohibiting a tight,
dry interface along residues Asp23-Ser26 as in the L-isoAsp
interface B.
The L-Asn side chain in the L-isoAsp interface B model may be
able to compensate for the loss of this dry interface by forming
another ladder of hydrogen bonds along the protofilament axis
(Fig. 4c, d right panel). Thus this second interface packing may be
achievable for a Aβ20–34, Asp23Asn structure as shown in the L-
isoAsp interface B model; however, the XRD patterns reveal that
the native Aβ20–34 and mutated Aβ20–34, Asp23Asn peptides share
more similarities than the isomerized Aβ20–34, isoAsp23 and the
Aβ20–34, Asp23Asn peptide. Both the native and heritable Iowa
mutant forms lack more defined peaks at 22.9, 24.7, 29.4, and
32.5, while both have more broad peaks at 30.9 Å (Fig. 4a, b).
These similarities between the Aβ20–34 and Aβ20–34, Asp23Asn
fiber diffractions patterns, and the lack of a methylene group
in the normal L-residues, may suggest that the Iowa mutant
Aβ20–34, Asp23Asn peptide will assume a structure more similar to
the native Aβ20–34 structure, as modeled in Fig. 4c, d (left panels).
This model maintains the backbone hydrogen bond between
Asn23 and Val24, the ordered core of the Aβ20–34 structure, and
allows for the additional polar zipper between stacked Asn23
residues. The added network of hydrogen bonds along the
asparagine side chain may explain in part the increased fiber
formation rates and stability of Aβ20–34, Asp23Asn against SDS and
heat denaturation. While the isomorphous powder diffraction
patterns seen between Aβ20–34, isoAsp23, Aβ20–34, Asp23Asn, and
Aβ20–34 do support the models in which Aβ20–34, Asp23Asn mimics
the native and isomerized structures, it cannot be ruled out that
Aβ20–34, Asp23Asn forms a distinct structure, perhaps lacking
either the L-Asp or the L-isoAsp novel interface B, with the
ordered core simply stabilized further by the Asn polar ladder.
Importantly, the powder diffraction of full-length Aβ and the
shorter peptide segments all display cross-β patterns with strong
reflections at ~4.7 and 9–10 Å (Fig. 4a), and the crystal structures
of Aβ20–34 and Aβ20–34, isoAsp23 form parallel, in-register beta-
sheets similar to other full-length Aβ structures. Thus we
hypothesized that the Aβ20–34, isoAsp23 structure could form the
core of a distinct isomerized Aβ polymorph. To visualize a
potential full-length fiber with the Aβ20–34, isoAsp23 structure as its
core, we added the remaining residues of Aβ 1–42 onto the ends
of the Aβ20–34, isoAsp23 protofilaments and energy minimized the
entire model as described in the “Methods” section. The resulting
model demonstrates that the remainder of the residues of Aβ
1–42 can be accommodated in a favorable conformation with the
isomerized segment as a core with interface A or B as the primary
interface (Fig. 5).
Comparison of segment structures to known Aβ structures.
The structures presented here are the longest segments of an
amyloid peptide determined by crystallography—four residues
longer than the previous amyloid spines determined by
MicroED30–33. This extension is significant due to the fact that, as
the number of residues in a segment grows, the packing of
idealized β-strands in a lattice becomes more difficult owing to
the strain created by the natural twist of the β-sheet/strand. This
strain hypothesis is consistent with observations that, as the
number of residues in an amyloid segment grows, the crystals that
can be grown are correspondingly smaller45. In the literature to
date, the crystal structures of shorter segments of amyloid pro-
teins have revealed that the dominant forces stabilizing proto-
filaments occur between different peptide chains46. In the native
and modified Aβ20–34 structures, we are not only able to see
interactions between protofilaments, such as the interfaces A and
B, but we also see folding of the peptide to produce a β-helix-like
Fig. 3 Aβ20–34, isoAsp23 structure contains an altered protofilament interface. a Representative single crystal electron diffraction pattern of Aβ20–34 with
resolution rings obtained during microcrystal electron diffraction (MicroED) data collection. Left inset shows the diffracting crystal (lower left scale bar
represents 1 μm). Right inset shows light microscopic image of microcrystal sediment in a 1.6-mL microfuge tube (scale bar represents 3 mm). b One layer
of the Aβ20–34 crystal structure viewed down the fibril axis highlighting two distinct steric zipper interfaces. Interface distances are labeled (center circle
indicates fibril axis). Waters are represented by red crosses. The 2Fo− Fc density is shown as a gray mesh at 2σ on the center protofilament. The Asp23
residue is outlined in magenta and shown by the red arrow. c Three layers of the Aβ20–34 structure viewed perpendicular to the fibril axis (indicated by
arrows; Left panel—interface A, right panel–L-Asp interface B). d Representative single crystal electron diffraction pattern of Aβ20–34, isoAsp23 with
resolution rings obtained during MicroED data collection. Left inset shows the diffracting crystal (lower left scale bar represents 1 μm). Right inset shows a
light microscopic image of microcrystal sediment in a 1.6-mL microfuge tube (scale bar represents 3 mm). e One layer of the Aβ20–34, isoAsp23 crystal
structure viewed down the fibril axis highlighting two distinct steric zipper interfaces. Interface distances are labeled (center circle indicates fibril axis).
Waters are represented by red crosses. The 2Fo− Fc density is shown as a gray mesh at 2σ on the center protofilament. The L-isoAsp23 residue is outlined
in magenta and shown by the red arrow. f, Three layers of the Aβ20–34, isoAsp23 structure viewed perpendicular to the fibril axis (indicated by arrows; Left
panel—interface A, right panel—L-isoAsp interface B)
Table 1 Data collection and refinement statistics
Aβ20–34 Aβ20–34, isoAsp23
Data collection
Space group P21 P21
Cell dimensions
a, b, c (Å) 33.17, 4.78, 30.33 29.20, 4.87, 32.44
α, β, γ (°) 90.00, 111.10, 90.00 90.00, 101.90, 90.00
Resolution (Å) 1.10 (1.13–1.10)a 1.05 (1.20–1.05)b,c
Rsym or Rmerge (%) 18.9 19.7
I/σI 5.41 (3.28) 3.76 (1.38)
Completeness (%) 85.2 82.7 (53.0)
Redundancy 6.67 (6.14) 4.19 (3.10)
Refinement
Resolution (Å) 7.74–1.10 (1.26–1.10) 5.96–1.05 (1.20–1.05)
No. of reflections 3544 (1141) 3943 (1167)
Rwork/Rfree (%) 19.4/21.3 (21.3/26.9) 19.7/24.6 (27.0/32.4)
No. of atoms
Protein 210 204
Ligand/ion 0 0
Water 7 4
B-factors
Protein 6.50 8.29
Ligand/ion — —
Water 20.78 27.70
R.m.s. deviations
Bond lengths (Å) 0.56 1.04
Bond angles (°) 0.68 0.90
aTen crystals were used in determining the Aβ20–34 structure
bFive crystals were used in determining the Aβ20–34, isoAsp23 structure
cValues in parentheses are for the highest-resolution shell
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turn with a hydrophobic core of interacting residues within the
same chain.
While not all full-length native structures contain β-arches,
such as the peptide dimer structure shown in Schmidt et al.47
(PDB code: 5AEF), all do include ordered cores involving steric
zippers similar to those found in shorter amyloid peptide
structures, and a majority of the known Aβ structures do display
β-helix-like turns as seen in the segment structures (Fig. 6 and
Supplementary Fig. 5). The native Aβ20–34 structure aligns well
with a number of these full-length Aβ structures, and both the
native and isomerized structures presented here have the lowest
total atom root-mean-square deviation (RMSD) with a structure
of the Aβ Osaka mutant29, E22Δ, at 2.741 and 2.963 Å,
respectively. A tree representing the structural relationships
between residues 20 and 34 of eight full-length Aβ structures and
our Aβ20–34 structure based on total atom RMSD values shows
that 6 of the 8 structures contain turns about the Gly25 and Gly29
residues21,23,24,26,28,29, creating interfaces which align well with
interface B of our L-Asp Aβ20–34 structure. Four21,23,26,29 of these
structures correspond to both the Aβ20–34 segment structures
with regard to the placement of charged residues Glu22, Asp23,
and Lys28 outside the hydrophobic core and yield total atom
RMSD values of ≤4 Å with Aβ20–34 (Fig. 6 and Supplementary
Fig. 5). These strong overlaps between our segment structure and
other full-length Aβ structures support the validity of this
segment as an atomic resolution structure of an Aβ core.
Importantly, in each of the full-length structures shown here, the
putative interface B is accessible as a possible secondary
nucleation site (Fig. 6). This interface is stabilized within our
structures by the L-isoAsp modification, which mates more
tightly between protofilaments than the L-Asp interface B and
excludes waters. Thus a full-length structural polymorph with this
interface may be isolated more readily with the modification.
The increased structural complexity afforded by extending
from 11 to 15 residues is appreciated best in comparing the
crystal structures of Aβ20–34 to the shorter Aβ 24–34 crystal
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Aβ20–34, Asp23Asn. All fibers including Aβ 1–42 were prepared in 50mM Tris, pH 7.6, 150mM NaCl, and 1% dimethyl sulfoxide (DMSO), except
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structure, 5VOS32 (Fig. 7). The four extra N-terminal residues in
both native and modified Aβ20–34 facilitate formation of kinks at
Gly25 and Gly29, creating an internal core, whereas the Aβ 24–34
peptide assumes a linear β-strand. Despite Aβ 24–34 lacking these
kinks, there is remarkable alignment between residues Gly29 to
Leu 34 and interface A of the Aβ20–34 crystals, yielding a total
atom RMSD of 0.70 and 0.68 Å with the native and isomerized
forms, respectively (Fig. 7). An inhibitor was previously
developed to the human islet amyloid polypeptide (hIAPP) steric
zipper interface analogous to this interface of the 5VOS Aβ
24–34 segment and was shown to be effective against fibril
formation of both hIAPP and full-length Aβ32. Given the striking
alignment between our Aβ20–34 interface A and the 5VOS Gly29-
Leu34 segment, as well as the distinct lack of modifications and
mutations in the region of Asn27-Gly33, this interface may be an
ideal scaffold for Aβ inhibitor design in both its homotypic steric
zipper form as shown here or in the heterotypic zippers displayed
in many of the full-length Aβ structures (Fig. 6).
Discussion
The typical age of onset for sporadic AD is after 65 years, sug-
gesting that slow spontaneous processes such as the accumulation
of age-dependent PTMs in Aβ may be contributing factors to
aggregation and toxicity4. The spontaneous isomerization of
aspartate (isoAsp) has been identified at all three aspartate resi-
dues within the Aβ 1–42 peptide—1, 7, and 23. However,
immunohistochemical studies have shown that, while native Aβ
and isoAsp7 Aβ are present in senile plaques from four non-
disease patient controls, isoAsp23 Aβ was identified only in one
of the four non-disease patient controls, as well as in the senile
plaques from all AD patient samples, indicating that the isoAsp23
may be more specifically associated with AD pathology than
native Aβ and the L-isoAsp7 form10. This implied pathogenicity
of isoAsp23 correlates with in vitro studies, which have
demonstrated accelerated amyloid formation of the isoAsp23 Aβ
1–40 and 1–42 peptides compared to native Aβ10,11,17,18,20. These
results suggest that the change in the structure of Aβ accom-
panying isomerization at Asp23 may represent a route to the
pathogenesis of AD.
In this work we present the 1.1 Å structures of segments
spanning residues 20–34 of the Aβ peptide containing either an
Asp or an isoAsp residue at site 23. These 15-residue segments,
crystallized at physiological pH, maintain a topology seen in the
core of Aβ fibrils, a β-helix-like turn (Fig. 6). The length of these
peptides facilitates their similar overall fold to previous WT Aβ
fibril structures and demonstrates that amyloid cores are rigid
and ordered enough to form crystals. These structures reveal a
previously unseen protofilament interface (B) involving residues
Asp23-Lys28 in the native structure, and residues L-isoAsp23-
Ser26 in the isomerized structure. The native interface (L-Asp
interface B) has low surface complementarity and contains six
water molecules encased between charged residue pairs Asp23
and Lys28 on opposing sheets. In contrast, the isomerized
interface (L-isoAsp interface B) is a dry tightly mated sheet with
high surface complementarity. Our data suggest that the changes
in the structure along this interface, namely, the exclusion of
water molecules and van der Waals attractive forces associated
with the high Sc, are likely responsible in part for the increases in
fiber formation rate and stability of the aggregate observed for the
isomerized peptide. The modified interface may provide a better
site for secondary nucleation of amyloid formation resulting in
the observed enhancements in aggregation. However, it cannot be
ruled out from the data presented here that the flexibility
imparted by the methylene group of the L-isoAsp residue pro-
motes amyloid formation by allowing an ordered nucleus for
primary nucleation to form at a faster rate than the native
peptide.
Our models of Asn23 in the Aβ20–34, isoAsp23 “L-isoAsp
interface B” indicate that the completely dry interface may be
possible for native residues (Fig. 4). However, the native Aβ20–34
structure did not preferentially adopt this interface and instead
forms a hydrated L-Asp Interface B. Similar to our Aβ20–34
peptide structure, alignments of previous Aβ structures onto the
Aβ20–34 and Aβ20–34, isoAsp23 protofilaments show the native
Asp23 side chain carboxyl group protruding into the putative
interface B region (Supplementary Fig. 5). The hereditary Iowa
mutant nuclear magnetic resonance (NMR) structure (Fig. 6 and
Supplementary Fig. 5 (PDB: 2MPZ22)) kinks at Gly25 and Asn27,
rather than at Gly25 and Gly29, and thus there is no equivalent
interface A. Yet, our preparations of crystals in TBS of the
Aβ20–34, Aβ20–34, isoAsp23, and Aβ20–34, Asp23Asn constructs
appear nearly identical by XRD, suggesting that the structure of
an Iowa mutant protofilament would resemble the native and
isomerized structures presented here (Fig. 4), barring minor dif-
ferences due to packing polymorphisms or different environ-
mental conditions.
It is clear that both the isomerization and Iowa mutation at
residue 23 accelerate aggregation and increase stability of Aβ
fibrils. Our structures of Aβ20–34 and Aβ20–34, isoAsp23 reveal a
potential mechanism for the increases in fiber formation rate and
fiber stability within the isoAsp23 form: the addition of a com-
pletely dry interface with high surface complementarity. This
analysis leads to the hypothesis that the Asp23 isomerization
in vivo could lead to the accelerated formation of Aβ fibrils,
thereby contributing to the aggregation of Aβ and AD pathology.
The hereditary Iowa mutation Asp23Asn may work in a similar
manner either by forming the same fold as the isomerized Asp23
or, since Asn undergoes isomerization more rapidly relative to
Asp, may also produce an isomerized Aβ with accelerated
aggregation and increased stability. The isomerized structure may
a
Interface A
9.1 Å
Interface B
4.0 Å
b
isoD23
isoD23
Fig. 5 Model of Aβ20–34, isoAsp23 as the core of an Aβ 1–42 modified
polymorph. a Model of Aβ1–42, isoAsp23 centered on interface A. b Centered
on interface B. Blue residues correspond to the crystal structure core
(Aβ20–34, isoAsp23), gray sticks correspond to the modeled extension (1–19
and 35–42)
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also provide insight into the mechanisms behind the A21G,
E22G, and E22Δ hereditary mutations that introduce flexibility
into the same region of the backbone. Importantly, we have also
found that the only known repair pathway for L-isoAsp, the
enzyme PCMT1, is unable to fully methylate and repair aggre-
gates of Aβ20–34, isoAsp23 in vitro, thus once the modified aggre-
gates have formed in vivo they may be difficult to repair and clear
(Supplementary Fig. 1).
Recent structures of tau isolated from AD patients have
revealed distinct structural polymorphs48. Both the paired helical
filaments and the straight filaments of tau display β-arches in their
sheets, which is a feature also shared by the native and isomerized
Aβ20–34 structures (Fig. 6 and Supplementary Fig. 4). This simi-
larity not only suggests that our structure’s β-helix-like turn may
be a common amyloid motif but also identifies a potential cross-
seeding site between Aβ and the tau protein of AD. This discovery
emphasizes the need for atomic-resolution structures of disease-
associated amyloid, as these core segments are critical for
structure-based drug design and protein prediction efforts49–52.
These crystal structures can be used in conjunction with full-
length cryo-EM structures to obtain a high-resolution view of the
interactions mediating amyloid fiber formation53. High-resolution
structures are also valuable when looking at the effect PTMs may
have on amyloid structure as seen here and elsewhere54. There-
fore, the combination of increasing peptide length and high
resolution makes the Aβ20–34 and Aβ20–34, isoAsp23 structures an
important step forward for the structural characterization of
amyloid proteins and their role in disease.
Methods
Materials. Aβ20–34 peptides corresponding to the human sequence were purchased
from and validated by Genscript at a purity of ≥98% as the trifluoroacetic acid
salt and were stored at −20 °C. Peptides were validated by electrospray
ionization–mass spectrometry (ESI-MS) performed by Genscript. Aβ 1–42 was
purchased from Bachem Americas, Inc. (Catalog #, H-1368).
Aggregation of Aβ20–34 peptides for fibril-formation rates. Peptides were
dissolved at 1.6 mM in 50 mM Tris-HCl, pH 7.6, 150 mM NaCl (TBS) with 2.5%
DMSO unless otherwise designated in the figure legend. Peptides solutions were
filtered through 0.22-μm cellulose acetate Costar Spin-X centrifuge tube filters
(Corning Inc., product #8161). Filtered peptide solutions in a final volume of
100 μL/well in a 96-well plate (Fisherbrand, 12565501) were read at 340 nm in a
Varioskan plate reader at 37 °C with continuous shaking at 1200 rpm. Readings
were recorded every 15 min.
Amyloid β (20–34) (D23→ isoD)
Nonpolar
Polar
Glycine
Acidic
Basic
Amyloid β (1–42) (5kk3) Amyloid β (1–42) (2nao)
Amyloid β (1–40) (2Imn)Amyloid β (1–42) (2beg)
Amyloid β (1–42) (2mxu)
Amyloid β (1–40) (E22Δ Osaka mutant (2mvx)
Amyloid β (1–40) (D23N lowa mutant (2mpz)
Amyloid β (1–42) (5oqv)
10 Å
Fig. 6 Aβ20–34, isoAsp23 core assumes a similar fold to full-length native Aβ structures. Schematic diagrams of residues 20–34 of previously solved Aβ
structures21–26,28,29. The structures most divergent from Aβ20–34, isoAsp23 are shown in the bottom row. Residues are colored according to general
chemical properties (legend—top left)
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Seeding of Aβ20–34 segment. Seeds were formed shaking continuously on an
acoustic resonant shaker at 37 °C at a frequency setting of 3733,34. Seeds of Aβ20–34
were formed at 5 mg/mL in 50 mM Tris-HCl, pH 7.6, 150 mM NaCl (TBS) with 1%
DMSO; seeds of Aβ20–34, isoAsp23 were formed at 2.5 mg/mL in 50 mM Tris-HCl,
pH 7.6, 150 mM NaCl (TBS) with 1% DMSO; and seeds of Aβ20–34, Asp23Asn were
formed at 2.5 mg/mL in 100 mM Tris-HCl, pH 7.5, 10% isopropanol, and 200 mM
sodium acetate. All seeds were diluted to 200 μM stocks and 5 μL were added to
3.2 mM Aβ20–34 in a final volume of 100 μL. Not all wells of the unseeded 3.2 mM
Aβ20–34 condition aggregated within the time course of this assay (Fid. 1d).
Solutions were read in a 96-well plate at 340 nm in a Varioskan plate reader at
37 °C with continuous shaking at 1200 rpm. Readings were recorded every 15 min.
Synthesis and purification of native Aβ 1–40. The syntheses of Aβ (1–40) WT
and Aβ (1–40) IsoAsp23 were completed in a CEM Liberty BlueTM Microwave
Peptide Synthesizer. The crude peptides were purified using an Interchim puri-
Flash® 4125 Preparative Liquid Chromatography System. Details of the syntheses
and purifications are available in the Supplementary Methods section (Supple-
mentary Tables 1–3, Supplementary Figs. 6–22).
The purified Aβ (1–40) WT has an estimated purity of 93% by high-
performance liquid chromatography (HPLC; Supplementary Figs. 14 and 15) and
was characterized by ESI-MS via direct injection into a Q-ExactiveTM Plus Hybrid
Quadrupole-Orbitrap TM Mass Spectrometer (Supplementary Figs. 16 and 17).
The calculated average mass for C194H295N53O58S: 4327.148 g/mol, m/z calculated:
[M+3H]3+= 1443.39; [M+4H]4+= 1082.79; [M+5H]5+= 866.44; [M+6H]6+=
722.20. Observed: 1443.3913; 1082.7955; 866.4374; 722.1991. The purified Aβ
(1–40) IsoAsp23 has an estimated purity of 97% by HPLC (Supplementary Figs. 19
and 20) and was characterized by ESI-MS via direct injection into a Q-ExactiveTM
Plus Hybrid Quadrupole-Orbitrap TM Mass Spectrometer (Supplementary Figs. 21
and 22). The calculated average mass for C194H295N53O58S: 4327.148 g/mol, m/z
calculated: [M+3H]3+= 1443.39; [M+4H]4+= 1082.79; [M+5H]5+= 866.44.
Observed: 1443.3912; 1082.7959; 866.4373.
Crystallization of the segments. Aβ20–34 was resuspended at a concentration of
3.2 mM in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl (TBS) with 1% DMSO in a final
volume of 100 μL. The peptide solution was then shaken continuously for 30 h at
1200 rpm at 37 °C. Aβ20–34,isoAsp23 was resuspended at a concentration of 1.6 mM
in 50 mM Tris-HCl, pH 7.6, 150 mM NaCl (TBS) with 1% DMSO in a final volume
of 200 μL. The filtered peptide solution was then shaken for 2 days on an acoustic
resonant shaker at 37 °C at a frequency setting of 3724,25. Four microliters of this
suspension was then used to seed 196 μL of a second peptide solution (1.6 mM) as a
2% seed on the acoustic resonant shaker at 37 °C. Crystals were obtained within
48 h. The presence of crystals was verified by EM, using a standard holder, with no
negative stain. Crystals of the native and isomerized segments were on average ~77
and ~71 nm in width, respectively, and were typically >2 μm in length.
MicroED sample preparation. Quantifoil R1.2/1.3 cryo-EM grids (Electron
Microscopy Sciences, product # Q325CR1.3) were glow discharged for 30 s on
either side, and 1.5 µL of a 1:1 dilution of Aβ20–34 crystals in 50 mM Tris-HCl, pH
7.5, 150 mM NaCl (TBS) with 1% DMSO was pipetted on both sides. Twenty
microliters of Aβ20–34,isoAsp23 crystal suspensions were spun down at 5000 × g for
5 min, the supernatant was removed, and pelleted crystals were resuspended in
50 μL TBS+ 0.75% (w/v) β-octyl-glucoside (VWR, P-1110), and rotated at 4 °C for
1 h. These detergent-treated crystals were then spun down a second time. Pelleted
crystals were resuspended in 50 μL water. A total of 1.5 μL of the washed crystal
solution was then applied on both sides of a glow discharged Quantifoil R1.2/1.3
cryo-EM grid (Electron Microscopy Sciences, product # Q325CR1.3). All grids
were plunge frozen into supercooled ethane using a Vitrobot Mark 4 instrument.
MicroED data collection and processing. MicroED data was collected in a
manner similar to previous studies42. Briefly, plunge-frozen grids were transferred
to an FEI Talos Arctica electron microscope and diffraction data were collected
using a bottom-mount CetaD 16M CMOS camera with a sensor size of 4096 × 4096
pixels, each 14 × 14 µm. Diffraction patterns were recorded by operating the
detector in continuous mode with 2 × 2 pixel binning, producing datasets with
frames 2048 × 2048 pixels in size. The exposure rate was set to <0.01 e−/A2/s. The
exposure time per frame was set at 3 s while the rotation speed was set to 0.3 deg/s
resulting in a final oscillation range of 0.9 deg/exposure for the Aβ20–34 data col-
lection and to 0.443 deg/s resulting in a final oscillation range of 1.329 deg/expo-
sure for the Aβ20–34,isoAsp23 data collection. This rotation rate was optimized to
allow a maximum amount of reciprocal space to be sampled before crystal decay
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N27K28
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I32
G33
L34
Aβ20–34, isoAsp23 
5VOS
Aβ20–34
Fig. 7 Aβ 24–34 peptide structure shares similarities with the Aβ20–34 structures. The Aβ steric zipper structure with the lowest total atom root-mean-square
deviation of all the short Aβ segment structures, PDB: 5VOS32 (orange), is shown aligned with interface A of Aβ20–34 (gold) and Aβ20–34, isoAsp23 (blue)
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was observed while also slow enough to prevent overlapping diffraction spots in the
diffraction images. Diffraction movies typically covered a 50–140 deg wedge of
reciprocal space and were taken of crystals randomly orientated on the grid with
respect to the incident beam. These crystals had a highly preferred orientation on
the grid, resulting in a systematic missing cone and hence lower completeness
along the c* axis; however, this did not preclude structure determination, with a
high overall completeness of >80% for both structures (see Table 1).
Structure determination. Diffraction datasets were converted to SMV format to
be compatible with the X-ray data processing software55. Data were indexed and
integrated using XDS56. The parameters controlling the raster size during indexing
and integration were optimized to reduce contributions by background and to
exclude intensities that conform poorly to the lattice determined during indexing.
The number of diffraction images used per crystal was aggressively pruned to
maximize I/σ. The resulting outputs from XDS were sorted and merged in
XSCALE. To produce a final merged dataset, partial datasets were selected based on
their effects on the Rmerge values. In total, for the Aβ20–34 structure, 10 partial
datasets, containing 404 diffraction images, were merged to produce a final dataset
with high completeness up to 1.1 Å. An ab initio solution was achieved using
SHELXD57. In total, for the Aβ20–34, isoAsp23 structure, 5 partial datasets, con-
taining 159 diffraction images, were merged to produce a final dataset with high
completeness up to 1.1 Å, and an ab initio solution was also achieved using
SHELXD. The phases obtained from both Aβ20–34 coordinates produced by
SHELX were used to generate maps of sufficient quality for subsequent model
building in Coot58. The resulting models were refined with Phenix59, using electron
scattering form factors, against the measured data.
Powder diffraction sample preparation and data collection. Designated aggre-
gates of Aβ 1–42 and Aβ20–34 peptides were prepared in buffers as described in the
figure legends. Aggregates were spun at 20,000 × g for 5 min. The pellet was
resuspended in water and re-spun. Pelleted fibrils were resuspended in 5 μL water
and pipetted between two facing glass rods that were 2 mm apart and allowed to
dry overnight at room temperature. These glass rods with ordered fibrils were
secured to a brass pin and mounted for diffraction at room temperature using
1.54 Å X-rays produced by a Rigaku FRE+ rotating anode generator equipped with
an HTC imaging plate. Patterns were collected at a distance of 200 mm and ana-
lyzed using the ADXV software package60.
SDS dissolution of aggregates. Aggregates of Aβ20–34, Aβ20–34, isoAsp23, and
Aβ20–34, Asp23Asn were all prepared in TBS, with 1%, 2.5%, and 2.5% DMSO,
respectively. Both Aβ20–34, isoAsp23 and Aβ20–34, Asp23Asn were prepared at a peptide
concentration of 2.5 mg/mL, while Aβ20–34 was prepared at 5 mg/mL, shaking at
1200 rpm at 25 °C. The Aβ20–34 was diluted to 2.5 mg/mL prior to the denaturation
assay. Suspensions of Aβ20–34 aggregates were diluted 1:1 in 2, 3, 4, and 10% SDS
stocks in TBS and heated for 15 min at 70 °C in a PTC-100 Peltier thermal cycler as
described by Guenther et al.54. Measurements at 340 nm were recorded on a
Nanodrop 2000 instrument. Two microliters of each solution was analyzed by EM
for remaining aggregates on glow discharged Formvar/Carbon 400 mesh, Copper
grids (Ted Pella, Catalog # 01754-F).
Analysis of Sa and surface Sc in Aβ20–34 structures. The structures of Aβ20–34
and Aβ20–34, isoAsp23 were used to measure buried surface area (Sa) and (Sc) from
an assembly consisting of two sheets generated by translational symmetry each
consisting of ten stacked β-strands. Sa was calculated as the average of the buried
surface area per chain and the difference between the sum of the solvent accessible
surface area of the two sheets and the solvent accessible surface area of the entire
complex, divided by the total number of strands in both sheets using the
CCP4 suite.
Modeling modified and full-length Aβ and RMSD calculations. Residues 1–42
of Aβ were modeled onto the N- and C-termini of the Aβ20–34, isoAsp23 structure
using Coot, and the resulting structures were energy minimized using the Crys-
tallography & NMR System (CNS)61 suite of programs.
Distance matrices for RMSD relationships between Aβ20–34, isoAsp23 and
residues 20–34 from native structures were generated in the LSQKAB program of
CCP4, and resulting matrices were used to generate the tree shown in Fig. 4.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Atomic coordinates and structure factors for the Aβ20–34 structure have been deposited
in the Protein Data Bank under accession code 6OIZ. The map for this structure has been
deposited in the EMDB with accession code EMD-20082. Atomic coordinates and
structure factors for the Aβ20–34, isoAsp23 structure have been deposited in the Protein
Data Bank under accession code 6NB9. The map for this structure has been deposited in
the EMDB with accession code EMD-0405. The source data underlying Figs. 1c, d, 2, and
4b and Supplementary Figs. 1 and 2 are provided as a Source Data file. Other data are
available from the corresponding author upon reasonable request.
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